Pharmacologic Agents Effective in Treating Chronic Insomnia

摘要

Chronic insomnia affects between 9 and 12 percent of U.S. adults and can impair mental health and quality of life. In this meta-analysis of randomized controlled trials, outcomes included sleep onset latency (the most commonly measured), wakefulness after sleep onset, sleep efficiency, and total sleep time.